Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer’s disease in a tertiary memory clinic

Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer’s disease in a tertiary memory clinic

Abstract Background Knowledge on the effect of analytical variability and storage conditions are essential for the successful implementation of plasma pTau217 in prospective settings. Aims To investigate the performance of plasma pTau217, measured in consecutive samples with LUMIPULSE, for detecting...

Full description

Saved in:

Bibliographic Details
Main Authors:	Javier Arranz, Rosa Ferrer, Nuole Zhu, Sara Rubio-Guerra, Íñigo Rodríguez-Baz, José Enrique Arriola-Infante, Lucía Maure-Blesa, Jesús Garcia-Castro, Judit Selma-González, María Carmona-Iragui, Isabel Barroeta, Ignacio Illán-Gala, Miguel Santos-Santos, Juan Fortea, Alberto Lleó, Mireia Tondo, Daniel Alcolea
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Alzheimer’s Research & Therapy
Subjects:	Stability Plasma Biomarkers Alzheimer Blood Amyloid
Online Access:	https://doi.org/10.1186/s13195-025-01779-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Early cerebrospinal fluid elevations of pTau-217 in severe traumatic brain injury subjects
by: Hamad Yadikar, et al.
Published: (2025-07-01)

Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217
by: Giulia Musso, et al.
Published: (2025-08-01)

Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unit
by: Lourdes Álvarez-Sánchez, et al.
Published: (2025-05-01)

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
by: Divya Bali, et al.
Published: (2025-06-01)

Immunoelectron microscopy and biochemical studies using three anti-tau antibodies in human brains: associations between pTau and ribosomes
by: Douglas Price, et al.
Published: (2025-07-01)

Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups
by: Heekyoung Kang, et al.
Published: (2025-08-01)

CDK5-mediated hyperphosphorylation of Tau217 impairs neuronal synaptic structure and exacerbates cognitive impairment in Alzheimer’s disease
by: Kangyue Fu, et al.
Published: (2025-08-01)

Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology
by: David Wilson, et al.
Published: (2025-07-01)

Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum
by: Anna Rennie, et al.
Published: (2025-08-01)

Analysis of the onset characteristics and diagnosis of 217 cases of renal tuberculosis
by: Chongbin Li, et al.
Published: (2025-06-01)

Scalable Synthesis of PtAu Nanoalloy-Decorated Hydrogenated TiO<sub>2</sub> for High-Efficiency Indoor Formaldehyde Photodegradation
by: Hairui Cai, et al.
Published: (2025-04-01)

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
by: Daniel Alcolea, et al.
Published: (2019-01-01)

New sizes of complete (k, 4)-arcs in PG(2,17)
by: Zainab Shehab Hamed
Published: (2023-04-01)

217. FAKTOR NEKROZA OPUKhOLI AL'FA PRI REVMATOIDNOM ARTRITE
by: S V Tsybul'ko, et al.
Published: (2000-08-01)

Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies
by: Ha-Lim Song, et al.
Published: (2024-10-01)

T-violating effect in $\nu_\tau (\bar{\nu}_\tau)-$nucleon quasielastic scattering
by: A. Fatima, M. Sajjad Athar and, S. K. Singh
Published: (2025-07-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-07-01)

Exploring Tau-C, Tau-A, and C1M as biomarkers for Parkinson’s disease
by: Meryem Benmarce, et al.
Published: (2025-04-01)

Metabolomic and genomic prediction of common diseases in 700,217 participants in three national biobanks
by: Nightingale Health Biobank Collaborative Group
Published: (2024-11-01)

Prospecting salivary tau as a diagnostic for Alzheimer’s type dementia
by: Gustavo Alves Andrade dos Santos, et al.
Published: (2025-04-01)

Improved reconstruction of highly boosted $$\tau $$ τ -lepton pairs in the $$\tau \tau \rightarrow (\mu \nu _{\mu }\nu _{\tau })(\text {hadrons}+\nu _{\tau })$$ τ τ → ( μ ν μ ν τ ) ( hadrons + ν τ ) decay channels with the ATLAS detector
by: ATLAS Collaboration
Published: (2025-06-01)

Flavouring Group Evaluation 217 Revision 3 (FGE.217Rev3): consideration of genotoxic potential for α,β‐unsaturated ketones and precursors from chemical subgroup 4.1 of FGE.19: lactones
by: EFSA Panel on Food Additives and Flavourings (FAF), et al.
Published: (2023-04-01)

Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
by: Abdolhossein Zare, et al.
Published: (2025-07-01)

Peripheral administration of blood from tau transgenic animals exacerbates brain tau-associated pathology.
by: Laura Vegas-Gomez, et al.
Published: (2025-01-01)

Peripheral administration of blood from tau transgenic animals exacerbates brain tau-associated pathology
by: Laura Vegas-Gomez, et al.
Published: (2025-01-01)

Research on the Impact of Illegal Direction: Confirmation or Verification ?! (Investigation of the Jurisprudence of Article 217 of the Civil Law)
by: Amin Suleiman Kolwanagh, et al.
Published: (2020-02-01)

Tau lepton averages by the HFLAV group
by: Alberto Lusiani
Published: (2025-07-01)

The Role of Tau in Neuronal Function and Neurodegeneration
by: Gonzalo Emiliano Aranda-Abreu, et al.
Published: (2025-05-01)

Lepton flavor violation with tau leptons
by: Julian Heeck
Published: (2025-07-01)

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
by: Rik Ossenkoppele, et al.
Published: (2021-07-01)

Measurement of the presence of $a_1(1420)$ and $\omega(782)$ in $\tau^{-}\to \pi^{-}\pi^{+}\pi^{-}\nu_{\tau}$ at Belle
by: Andrei Rabusov, Daniel Greenwald, Stephan Paul
Published: (2025-07-01)

Regulatory Role and Mechanism of lncRNA RNF217-AS1 in the Proliferation and Migration of Esophageal Cancer Cells
by: Liang J, et al.
Published: (2025-07-01)

Kwame A. Ninsin (ed.). 2016. Issues in Ghana’s Electoral Politics. Dakar: CODESRIA. 217 pp
by: Jan Prouza
Published: (2018-06-01)

CARM1 S217 phosphorylation by CDK1 in late G2 phase facilitates mitotic entry
by: Yena Cho, et al.
Published: (2025-03-01)

Ancient notching or tokening as bookkeeping – Evidence from wood slips in China during 217–210 BCE
by: Min Chen, et al.
Published: (2025-09-01)

Contributions of major tau kinase activation and phospho-tau accumulation to cortical and hippocampal tangle formation and cognition in older adults
by: Elena Hernández-Hernández, et al.
Published: (2025-06-01)

Educational outcomes in childhood cancer survivors: A Scotland-wide record-linkage study of 766,217 schoolchildren.
by: Nicholas Baughan, et al.
Published: (2023-01-01)

Discovery of Late Triassic (217 Ma) gabbro in the Yabulai District: Constraints on the Early Mesozoic evolution of the Alxa Block
by: Peng-fei Niu, et al.
Published: (2025-04-01)

Boosted Tau Lepton as a Microscope and Macroscope
by: Sitian Qian, et al.
Published: (2022-01-01)

The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease
by: Xiaoyue Hong, et al.
Published: (2025-06-01)